Andrew Day, M.D. Titles and Appointments Associate Professor Endowed Title Eugene P. Frenkel, M.D. Scholar in Clinical Medicine School Medical School Department Otolaryngology - Head & Neck Surgery You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Andrew T. Day, M.D., M.P.H., is an Assistant Professor of Otolaryngology – Head and Neck Surgery at UT Southwestern Medical Center. He is also a member of the Population Science and Cancer Control program at the Harold C. Simmons Comprehensive Cancer Center. Dr. Day earned his medical degree at the University of Minnesota Medical School. Following his residency in Otolaryngology – Head and Neck Surgery at Washington University in St Louis School of Medicine, he received advanced training in Head and Neck Oncologic Surgery and Microvascular Reconstruction at Johns Hopkins University School of Medicine. He then earned a Master of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. His clinical interests primarily include the management of benign and malignant tumors of the head and neck. He has specific expertise in complex ablative surgery, transoral laser microsurgery (TLM), transoral robotic surgery (TORS), reconstructive surgery, skin cancer and melanoma management, sentinel lymph node biopsy, open and minimally-invasive salivary gland surgery, and thyroid and parathyroid surgery. Dr. Day is a national leader in the fields of head and neck cancer, cancer survivorship, and cancer prevention. He is a member of the National Comprehensive Cancer Network (NCCN) Survivorship Panel and the former Vice-Chair (2022-2025). He co-led the Cancer Center (Tobacco) Cessation Initiative at the University of Texas Southwestern Medical Center (UTSW), which was a National Cancer Institute Cancer Moonshot program. He also serves on committees of the NRG, American Head and Neck Society (AHNS), and Head and Neck Cancer International Group (HNCIG). Dr. Day conducts research to screen for head and neck cancer and reduce the burden of head and neck cancer in survivors. He and his colleagues have been awarded grants from the National Cancer Institute, Cancer Prevention Research Institute of Texas, and the American Cancer Society. In his current projects, he is testing an online, head and neck cancer self-management program, developing strategies to help new head and neck cancer patients stop smoking, care pathway, and screening middle-aged men for HPV-mediated cancers. Dr. Day has authored over 75 peer-reviewed publications. He serves as an ad-hoc reviewer for Cancer, Oral Oncology, Head Neck, and JAMA Otolaryngology – Head and Neck Surgery. Education Medical School University of Minnesota (2010) Residency Washington University in St. Louis School of Medicine (2015), Otolaryngology Graduate School Johns Hopkins Bloomberg School of Public Health (2017), Public Health Fellowship Johns Hopkins Hospital (2017), Head & Neck Oncology & Microvascular Reconstructive Surgery Research Interest Early Detection of HPV-mediated Oropharyngeal Cancer Head and Neck Cancer Outcomes Head and Neck Cancer Survivorship Publications Featured Publications HYHOPE: A phase I study of de-intensified hypofractionated radiation therapy for human papillomavirus-associated oropharynx cancer. Moon DH, Avkshtol V, Hughes RS, Ahn C, Sumer BD, Day AT, Tillman BN, Myers LL, Truelson JM, Sher DJ, Int J Radiat Oncol Biol Phys 2025 May NCCN Guidelines® Insights: Survivorship, Version 2.2025. Sanft T, Day AT, Ansbaugh SM, Ariza-Heredia EJ, Armenian S, Baker KS, Ballinger TJ, Cathcart-Rake EJ, Cohen SH, Evgeniou E, Fairman NP, Feliciano J, Flores TF, Friedman DL, Gabel NM, Goldman ME, Hill-Kayser CE, Hock K, Kline-Quiroz C, Koura D, Lee NK, McDonough AL, Mooney K, Moore HCF, Moryl N, Neuman H, Overholser L, Patel CG, Peterson LL, Pirl WF, Porpiglia A, Rogers LQ, Saidain A, Schapira L, Smith SK, Tenne L, Tevaarwerk A, Ah DV, Yang EH, Zee P, McMillian N, Freedman-Cass D, J Natl Compr Canc Netw 2025 Jun 23 6 208-217 Protocol for a multisite, parallel-group, randomized clinical trial comparing a brief tele-cognitive behavioral therapy intervention (BRIGHT) with attention control for the reduction of body image-related distress among head and neck cancer survivors. Graboyes EM, Maurer SN, Kistner-Griffin E, Armeson K, Starr E, McLeod T, Balliet WE, Doenges J, Slavin-Spenny O, Vanderlan JR, Day A, Pipkorn P, Puram SV, Tam SH, Ruggiero KJ, Sterba KR, Contemp Clin Trials 2025 Mar 153 107888 Margin Status and Recurrence in Surgically Treated Patients With HPV+ Oropharyngeal Cancer. Ausburn M, Pyne JM, Day AT, Hajnas N, Moon D, Myers LL, Sher DJ, Truelson JM, Tillman B, Sumer B, Laryngoscope 2025 Mar Circulating tumor HPV DNA, antibodies to HPV16 early proteins, and oral HPV16 DNA as biomarkers for HPV-related oropharyngeal cancer screening. Dahlstrom KR, Day AT, Alvarez VM, Chirinos SR, Santillana G, Guo M, Anderson KS, Sturgis EM, Cancer Biomark 2025 Jan 42 1 18758592241313323 NCCN Guidelines® Insights: Survivorship, Version 2.2024. Sanft T, Day AT, Goldman M, Ansbaugh S, Armenian S, Baker KS, Ballinger TJ, Demark-Wahnefried W, Fairman NP, Feliciano J, Flores TF, Friedman DL, Gabel N, Hill-Kayser C, Koura D, Lee K, Lee N, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, Overholser L, Patel C, Peterson L, Pirl W, Porpiglia A, Schapira L, Schwartz A, Smith S, Tevaarwerk A, Von Ah D, Wake R, Yang E, Zee P, McMillian N, Freedman-Cass D, J Natl Compr Canc Netw 2024 Dec 22 10 648-658 Considerations in screening for asymptomatic carotid artery stenosis in irradiated head and neck cancer survivors. Day AT, Mitchell DN, Eary RL, Jones E, Pinho MC, Zaha VG, Yang EH, Sher DJ, Cancer 2024 Nov Clinical Management Update of Oral Leukoplakia: A Review From the American Head and Neck Society Cancer Prevention Service. Gates JC, Abouyared M, Shnayder Y, Farwell DG, Day A, Alawi F, Moore M, Holcomb AJ, Birkeland A, Epstein J, Head Neck 2024 Nov Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations. Lim AM, McDowell L, Hurt C, Le Tourneau C, Homma A, Shenouda G, Thomson DJ, Moya-Plana A, Henson C, Szturz P, Day AT, Bates JE, Lazarakis S, Thariat J, Psyrri A, Mehanna H, Yom SS, Lancet Oncol 2024 Jul 25 7 e318-e330 Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations. Lim AM, Le Tourneau C, Hurt C, Laskar SG, Steuer CE, Chow VLY, Szturz P, Henson C, Day AT, Bates JE, Lazarakis S, McDowell L, Mehanna H, Yom SS, Lancet Oncol 2024 Jul 25 7 e308-e317 Results 1-10 of 78 1 2 3 4 5 Next Last Books Featured Books Regional flaps. In Facial Plastic and Reconstructive Surgery: Clinical Reference Guide Day AT, Chaudhary HA, Richmon JD. (2016). San Diego, Plural Publishing, Inc. Radioiodine sialadenitis. In Gland-Preserving Salivary Surgery ? A Problem-Based Approach Day AT, Eisele DW. (2017). Berlin, Springer
